President, US Generics Division
- Appointed: 2015
- Joined Hikma: 2009
- Nationality: American
Skills and experience: Brian was appointed President of West-Ward Pharmaceuticals in 2015 with responsibilities for two of Hikma’s facilities, supply chain, business development, and product selection. He assumed responsibility for his current role in July 2017. Brian originally joined West-Ward in 2009 to develop a strategy function and was later promoted to VP Corporate Development and SVP & General Manager. Brian has led many strategic initiatives including the acquisitions and integrations of Baxter’s Multi-Source Injectables business and Boehringer Ingelheim’s Roxane Laboratories.
Brian worked for L.E.K. Consulting as a management consultant in their Boston office. He led engagements for clients in a wide variety of areas including growth strategy, merger evaluation and integration, new product launches, and strategic alliances.
Brian holds a Bachelor’s Degree in Business Administration from Boston University Questrom School of Management and an MBA from the University of Chicago Booth School of Business with concentrations in strategic management, finance, and marketing.
Other appointments: None